In the Reset Your Set Point program, a physician may prescribe patients semaglutide compounded with B-12 and glycine that is dispensed in a vial that allows for flexible dosing.
The cost of semaglutide starts at $139 for a 6-8 week supply.
Semaglutide is a GLP-1 receptor agonist that is FDA approved for weight loss under the brand name Wegovy and for type 2 diabetes under the brand name Ozempic. Semaglutide is taken as a weekly subcutaneous injection.
Clinical trials conducted by the manufacturer of Wegovy and Ozempic found that patients taking semaglutide for 68 weeks had a mean weight loss of
18% of starting body weight.
The most common side effects of semaglutide include nausea, diarrhea, and constipation, which usually lessen over time.
To learn if you might be eligible for weight loss treatment with semaglutide, take our quick
online assessment.